Status:
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Alzheimers Disease
Eligibility:
All Genders
50-90 years
Phase:
PHASE3
Brief Summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Eligibility Criteria
Inclusion
- \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD.
Exclusion
- Dependency in basic activities of daily living (bADLs) due to cognitive impairment
- Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
- Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
- History of severe, clinically significant central nervous system trauma
- Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
Key Trial Info
Start Date :
July 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2035
Estimated Enrollment :
13000 Patients enrolled
Trial Details
Trial ID
NCT07177352
Start Date
July 2 2025
End Date
July 31 2035
Last Update
December 19 2025
Active Locations (179)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Alzheimer?s Institute
Phoenix, Arizona, United States, 85006
2
Banner Sun Health Research Institute
Sun City, Arizona, United States, 85351
3
Sun Valley Research Center, Inc.
Imperial, California, United States, 92251
4
Inglewood Clinicals
Inglewood, California, United States, 90301